Oral Ganciclovir in Children: Pharmacokinetics, Safety, Tolerance, and Antiviral Effects
Lisa M. Frenkel(Infectious Disease Research Institute), Stephen A. Spector(University of California San Diego), Ann J. Melvin(University of Washington), Sandra Burchett(Harvard University), Irene L. Smith(University of California San Diego), Mary Culnane(National Institute of Allergy and Infectious Diseases), Edmund V. Capparelli(University of California San Diego), Jennifer S. Read(Foundation for Human Potential), Jonathan C. Goldsmith(National Heart Lung and Blood Institute), Anita Ballow, Amy L. Shaver(National Institute of Allergy and Infectious Diseases), Wayne M. Dankner(University of California San Diego), Ann Petru, Jing Xu(Harvard University), Andrea Kovács(University of Southern California), M. Stempien(Center for Global Development), K. Mohan(University of Washington), Charles A. Robinson(Center for Global Development), Michele Thompson(Social and Scientific Systems (United States)), Ram Yogev(Northwestern University), William Borkowsky(New York University), Elizabeth J. McFarland(University of Colorado Anschutz Medical Campus)
Cited by 47
Related Papers
Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
|New England Journal of Medicine|1994|3.7k
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Management of Sickle Cell Disease
|JAMA|2014|1.6k
Lymphocyte subsets in healthy children from birth through 18 years of age
|Journal of Allergy and Clinical Immunology|2003|828
Sjögren's syndrome. Proposed criteria for classification
|Arthritis & Rheumatism|1986|685